Polyclonal Myeloperoxidase Antibody now available from Lee Biosolutions

August 9, 2006; St. Louis, Missouri – Lee Biosolutions recently began carrying polyclonal myeloperoxidase (MPO) antibodies at www.LeeBio.com.

The polyclonal MPO antibody comes from a rabbit host. It forms a single precipition arc against human MPO by immunoelectrophoresis; however there is no reaction with the normal human serum.

To create the polyclonal MPO antibodies, Rabbits are immunized with highly purified human MPO. After multiple immunizations in Freund's adjuvant, the rabbits are bled and the serum is collected. The anti-human myeloperoxidase used is the affinity purified off an antigen containing immunoabsorbent.

“We’re focused on providing consistently pure products to the clinical research community,” Lee Biosolutions President Burton Lee said. “We continue to expand our product line based on the trends that we see developing in the industry.”

Lee Bio’s MPO has been qualified by major diagnostic companies and is currently being evaluated by researchers around the world working with MPO as a cardiac marker and autoimmune assay systems.

The company also recently launched www.MPOFacts.com, a web-based resource that connects clinical researchers worldwide with MPO-related news, information and communication opportunities.

Lee Biosolutions’ customers are clinical researchers around the world who rely on the company to provide the highest quality products to aid in the development of tomorrow’s cures.

For over 30 years, Lee Biosolutions has been providing proteins, enzymes and other materials to research facilities around the country that work to advance the healthcare industry. By providing Solutions on Demand, Lee Biosolutions has become the preferred source for materials such as renin and myeloperoxidase (MPO).

For more information or to place an order, contact Lee Biosolutions at 314-968-1091, or visit the company’s newly redesigned website, www.leebio.com.